Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)

Contract Value

Not provided

Codes & Classification
Solicitation Number

ARPA-H-SOL-26-163

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Classification Code

AN13

Additional Details
Set Aside

None

Place of Performance

UNITED STATES

SourceSAM
Documents5
The Advanced Research Projects Agency for Health (ARPA-H), operating under the Department of Health and Human Services and the National Institutes of Health, has issued a solicitation for the Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program. This initiative seeks to transform the understanding and management of autism by developing integrated systems that can identify, monitor, and influence the developmental trajectories of individuals with autism across their lifespan—from the prenatal period through aging. The SPECTRA program is designed to move beyond traditional, siloed approaches to autism research. Instead, it aims to examine the complex, nonlinear interactions among genetic, biological, behavioral, medical (iatrogenic), and environmental factors that contribute to autism and its co-occurring conditions. By focusing on how these factors combine and evolve over time, SPECTRA intends to generate a more holistic and actionable understanding of autism’s progression and variability. A key objective of SPECTRA is the development of dual-purpose technologies that not only extend reliable assessment capabilities beyond clinical settings but also enhance everyday communication, functional abilities, and overall quality of life for individuals with autism. These tools are envisioned to serve both as practical aids in daily living and as data collection platforms, generating rich, real-world information to inform measurement and enable personalized care strategies. The solicitation, identified by procurement number ARPA-H-SOL-26-163, falls under NAICS code 541715, which covers Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The Product Service Code associated with this opportunity is AN13. The place of performance is within the United States. The solicitation has undergone several amendments, reflecting updates and clarifications to technical areas and requirements, as well as the provision of additional attachments detailing proposal requirements and solution summary templates. Contractors are encouraged to review these amendments carefully to ensure compliance with the latest requirements. The SPECTRA program is seeking proposals from organizations with expertise in multidisciplinary research, technology development, and data integration relevant to autism and related conditions. Key deliverables are expected to include innovative assessment tools, data-driven models of autism trajectories, and solutions that can be deployed both in clinical and everyday environments. Interested parties should note that the opportunity is currently active, with a response deadline of February 12, 2026. All inquiries and submissions should be directed to the SPECTRA Team at [email protected]. Additional details, including solicitation documents and attachments, can be accessed via the official SAM.gov opportunity listing at https://sam.gov/opp/25b718f2257845f3880f6a7f41f9e5df/view. This procurement represents a significant opportunity for organizations specializing in life sciences research, health technology innovation, and data analytics to contribute to a transformative national effort in autism research and care. Contractors should ensure their capabilities align with the program’s emphasis on integrated, technology-enabled solutions and a systems-level approach to understanding and improving outcomes for individuals with autism.